Three key messages on tuberculosis control World Tuberculosis Day 2010 ECDC TB Team European Centre for Disease Prevention and Control Stockholm, 24 March.

Slides:

Advertisements

Similar presentations

World Tuberculosis Day 2013 TB situation in 2011: Findings from the ECDC and WHO/EURO joint TB surveillance report ECDC TB Team European Centre for Disease.

Advertisements

M. Samarkos TUBERCULOSIS IN GREECE. INTRODUCTION.

World Tuberculosis Day 2015 The TB situation in 2013: Findings from the joint TB surveillance and monitoring report by ECDC and the WHO Regional Office.

World Tuberculosis Day 2014 The TB situation in 2012: Findings from the joint TB surveillance and monitoring report by ECDC and the WHO Regional Office.

World Tuberculosis Day 2014 The TB situation in 2012: Findings from the joint TB surveillance and monitoring report by ECDC and the WHO Regional Office.

Tuberculosis in the UK 2013 report

Tuberculosis in the UK 2014 report

Surveillance report Annual Epidemiological Report on communicable diseases in Europe ECDC Surveillance Unit European Centre for Disease Prevention and.

The Global Plan to Stop TB, (1)

MDR-TB: a fight we cannot afford to lose! Alexander Golubkov, MD, MPH Senior TB Technical Advisor.

Tuberculosis in England 2015 report (presenting data to end of 2014) Tables and figures slide set.

Tuberculosis Surveillance in Europe EuroTB update March 2008 WHO Collaborating Centre.

Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.

2014 HIV/AIDS Surveillance in the European Union and European Economic Area (EU/EEA) European Centre for Disease Prevention and Control, Stockholm WHO.

2010 HIV/AIDS surveillance in Europe European Centre for Disease Prevention and Control, Stockholm WHO Regional Office for Europe, Copenhagen.

Table 1. Numbers and rates of TB cases per population by country and year, EU/EEA, 2010–2014 ASR: age-standardised rate, C: case-based Source:

Table 1. Criteria for differentiating acute and chronic hepatitis C Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological.

Table 1. Number and rate of reported confirmed syphilis cases per population by country and year, EU/EEA, 2010–2014 ASR: age-standardised rate,

Table 1. Number and rate of Legionnaires’ disease cases per population by country and year, EU/EEA, 2010–2014 ASR: age-standardised rate, C: case-based.

Table 1. Criteria for differentiating acute and chronic hepatitis B Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological.

World Tuberculosis Day 2016 Monitoring the implementation of the Framework Action Plan to Fight Tuberculosis in the European Union – Situation in 2014.

Table 1. Confirmed cases of Typhoid and paratyphoid fever: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y.

TUBERCULOSIS IN JAPAN ANNUAL REPORT – 2016.

Table 1. New HIV diagnoses by country, EU/EEA, 2010–2014

Figure 1. Weekly proportion of sentinel specimens positive for influenza virus and number of detections by type and subtype, EU/EEA, 2014–2015 Suggested.

Table 1. Reported confirmed hepatitis A cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N =

World Tuberculosis Day 2014

World Tuberculosis Day 2013

World Tuberculosis Day 2014

Table 1. Cases of reported, confirmed cases of invasive meningococcal disease: number and rate per population, EU/EEA, 2010–2014 Country

Country Cases Rate National data Report type

Figure 1. Number of reported hantavirus infection cases, EU/EEA, 2014

Country Cases Rate National data Report type

World Tuberculosis Day 2015

Monitoring the implementation of the TB Action Plan for the WHO European Region, 2016–2020 EU/EEA situation in 2016 ECDC Tuberculosis Programme European.

Table 1. Cases of reported, confirmed cases of invasive pneumococcal disease: number and rate per population, EU/EEA, 2010–2014 Country

Cases Rate National data Report type

Table 1. Reported, confirmed campylobacteriosis cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes,

Table 1. Number and rate of reported confirmed syphilis cases per 100 000 population by country and year, EU/EEA, 2010–2014 Country

Table 1. Reported confirmed brucellosis cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N =

Tuberculosis situation in the EU/EEA, 2016

HIV/AIDS Surveillance in Europe 2011

Gonorrhoea cases of gonorrhoea were reported by 27 EU/EEA Member States for The overall notification rate was 18.8 cases per 100 000 population.

World Tuberculosis Day 2014

World Tuberculosis Day 2016

World Tuberculosis Day 2014

Table 1. Table 1. Reported confirmed salmonellosis cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y.

Table 1. Reported confirmed VTEC infection cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N.

Table 1. Reported confirmed cholera cases, EU/EEA, 2010–2014

Table 1. Reported confirmed botulism cases: number and rate per population, EU/EEA, 2010–2014 ASR: age-standardised rate, C: case-based Source:

Lymphogranuloma venereum (LGV)

Country Cases Rate National data Report type

Country Cases Rate National data Report type

Table 1. Reported confirmed leptospirosis cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N.

Tuberculosis in Wales Annual Report 2018 Data to the end of 2017

Chlamydia In 2016, cases of chlamydia infection were reported in 26 EU/EEA Member States. The overall notification rate was 184 per 100 000 persons.

Success and failure in TB surveillance in Hungary

DOTS IMPACT TO TUBERCULOSIS IN LITHUANIA

Table 1. Confirmed cases of trichinellosis: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N = no,

Country Cases Rate National data Report type

Trends for ECDC measles and rubella monitoring,

Table 1. Reported confirmed listeriosis cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N =

Tuberculosis situation in the EU/EEA, 2017

Table 1. Table 1. Reported confirmed toxoplasmosis cases: number and rate per live births, EU/EEA, 2010–2014 Source: Country reports. Legend: Y.

Source: Country reports

Annual Epidemiological Report for 2017 Sexually Transmitted Diseases - chlamydia - gonorrhoea - lymphogranuloma venereum - (congenital) syphilis.

Tuberculosis situation in the EU/EEA, 2017

Tuberculosis in Wales Annual Report 2017 Data to the end of 2016

Tuberculosis situation in the EU/EEA, 2017

Table 1. Reported confirmed yersiniosis cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N =

Presentation transcript:

Three key messages on tuberculosis control World Tuberculosis Day 2010 ECDC TB Team European Centre for Disease Prevention and Control Stockholm, 24 March 2010

Message 1 The treatment success rate in the EU/EEA is too low to meet global targets

1a. The treatment success rate in the EU/EEA is too low to meet global targets Reported treatment success rates in the EU/EEA are far below the 85% target set by the WHO World Health Assembly. Only three EU/EEA countries recorded a treatment success rate over 85% or more for new laboratory-confirmed pulmonary TB cases. * Treatment success rate among not previously diagnosed cases. Source: ECDC 85% target set by the Stop TB Partnership. Only Iceland, Portugal and Slovakia meet the 85% target. Figure 1a: Treatment success rate among new laboratory- confirmed pulmonary TB cases, 2007

1b. The treatment success rate in the EU/EEA is too low to meet global targets Figure 1b: Percentage success rate among laboratory- confirmed new pulmonary TB cases, EU/EEA, to 84% ≥ 85% 60 to 70% < 60% Not included or not reporting Source: ECDC

1c. The treatment success rate in the EU/EEA is too low to meet global targets Treatment success among previously untreated laboratory-confirmed pulmonary TB remains low in the EU/EEA and is below the 85% target. No changes in the trend were seen in the last five years. Figure 1c: EU/EEA treatment outcome among laboratory- confirmed pulmonary cases 2003–2007 Success Died Failed Defaulted Still on treatment Transferred or unknown * Excluded: Austria, Bulgaria, Cyprus, Finland, France, Greece, Italy, Liechtenstein and Spain

Message 2 Multidrug-resistant tuberculosis (MDR TB) remains a problem in the EU/EEA

2a. MDR TB* remains a problem in the EU/EEA Figure 2a: Proportion of notified TB cases with primary multidrug resistance, EU/EEA, to 5.9% > 10% 1 to 1.9% > 6-10% < 1% Not included or not reporting * Multidrug-resistant tuberculosis (MDR TB) is defined as TB that is resistant at least to isoniazid (INH) and rifampicin (RMP), the two most powerful first-line anti-TB drugs.

2b. MDR TB remains a problem in the EU/EEA Treatment success rate among MDR TB cases is extremely low (31%). 78% 31% 7% 17% 3% 17% 6% 13% 2% 17% 5% MDR SuccessDiedFailedDefaultedStill on treatment Transferred or unknown Figure 2b: Treatment outcome of all* MDR TB cases, compared to all non-MDR cases, EU/EEA, 2006** * Pulmonary and extra-pulmonary** Both groups are 2006 treatment cohorts Non-MDR

Message 3 The decline in tuberculosis has levelled off in the EU/EEA

3a. The decline in tuberculosis has levelled off in the EU/EEA Figure 3a: TB notification rates by incidence grouping, 1995–2008 and 2002–2008 Source: ECDC The decrease in TB notification rates has stagnated in the EU/EEA. The decline seen in countries with high and intermediate incidence rates contributes substantially to the average EU/EEA decline. <20/ EU/EEA >20/ Notification rate (per population)

3b. The decline in tuberculosis has levelled off in the EU/EEA Notification rate (per population) Figure 3b: TB notification rates, 1995–2008, EU/EEA